Salivary Glycated Albumin
Not Applicable
Withdrawn
- Conditions
- Diabetes Mellitus
- Registration Number
- NCT03235492
- Lead Sponsor
- University of Maryland, Baltimore
- Brief Summary
(1) to determine whether the ratio of glycated albumin and total albumin in saliva is equivalent to blood and (2) to investigate whether the non-invasive SmartAlbu portable salivary sensor is as accurate as standard tests that measure glycosylated hemoglobin (HbA1c).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- 123 individuals with type 1 or type 2 diabetes
- 53 non diabetic controls
- Age: 18 to 80
- Body mass index >18.5kg / m2
Exclusion Criteria
- Acute illness (within 7 days) - respiratory infection, fever above 38 °C, sinusitis infection, severe allergies.
- Individuals with known sickle cell, pregnancy, hemoglobinopathies, renal failure
- Subjects unable to give voluntary informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Salivary glycated albumin vs. glycosylated hemoglobin (HbA1c) 30 min To investigate whether the non-invasive SmartAlbu portable salivary sensor is as accurate as standard tests that measure HbA1c.
Salivary glycated albumin vs. blood glycated albumin 30 min Whether the ratio of glycated albumin and total albumin in saliva is equivalent to blood.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Maryland
🇺🇸Baltimore, Maryland, United States
University of Maryland🇺🇸Baltimore, Maryland, United States